Raphael Pharmaceutical annual current ratio
2020
2021
2022
2023
2024
2025
Raphael Pharmaceutical Current Ratio Growth & History (RAPH)
Raphael Pharmaceutical's current ratio was 0.03 for fiscal 2025.
View full Raphael Pharmaceutical company overviewRaphael Pharmaceutical annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.03 | 0.00 | +5.57% |
| 2024 | 2024-12-31 | 0.03 | −1.76 | −98.19% |
| 2023 | 2023-12-31 | 1.80 | 0.34 | +23.13% |
| 2022 | 2022-12-31 | 1.46 | 0.02 | +1.59% |
| 2021 | 2021-12-31 | 1.44 | 0.55 | +62.65% |
| 2020 | 2020-12-31 | 0.88 | — | — |
Raphael Pharmaceutical quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.00 | −0.02 | −87.79% |
| Q1 2026 | 2026-03-31 | 0.00 | −0.11 | −99.45% |
| Q4 2025 | 2025-12-31 | 0.03 | 0.00 | +5.57% |
| Q3 2025 | 2025-09-30 | 0.00 | −0.07 | −94.65% |
| Q2 2025 | 2025-06-30 | 0.03 | −0.28 | −91.38% |
| Q1 2025 | 2025-03-31 | 0.11 | −0.66 | −85.66% |
| Q4 2024 | 2024-12-31 | 0.03 | −1.76 | −98.19% |
| Q3 2024 | 2024-09-30 | 0.07 | −0.77 | −91.26% |
| Q2 2024 | 2024-06-30 | 0.30 | −0.35 | −54.02% |
| Q1 2024 | 2024-03-31 | 0.77 | −0.17 | −18.09% |
| Q4 2023 | 2023-12-31 | 1.80 | 0.34 | +23.13% |
| Q3 2023 | 2023-09-30 | 0.84 | 0.19 | +29.33% |
| Q2 2023 | 2023-06-30 | 0.66 | −1.86 | −73.91% |
| Q1 2023 | 2023-03-31 | 0.94 | −1.40 | −59.91% |
| Q4 2022 | 2022-12-31 | 1.46 | 0.02 | +1.59% |
| Q3 2022 | 2022-09-30 | 0.65 | 0.32 | +96.13% |
| Q2 2022 | 2022-06-30 | 2.51 | — | — |
| Q1 2022 | 2022-03-31 | 2.34 | — | — |
| Q4 2021 | 2021-12-31 | 1.44 | 0.55 | +62.65% |
| Q3 2021 | 2021-09-30 | 0.33 | — | — |
| Q4 2020 | 2020-12-31 | 0.88 | — | — |
Raphael Pharmaceutical current ratio trends
Over the last five fiscal years, Raphael Pharmaceutical's current ratio decreased from 0.88 to 0.03, a change of −0.85. The latest reported quarter, Q2 2026, shows 0.00.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Raphael Pharmaceutical source filings ↗